IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.068
AS - Asia 1.956
EU - Europa 1.347
SA - Sud America 292
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.985
SG - Singapore 648
IE - Irlanda 556
CN - Cina 499
HK - Hong Kong 294
VN - Vietnam 238
BR - Brasile 215
RU - Federazione Russa 204
FR - Francia 121
ZA - Sudafrica 119
DE - Germania 113
IT - Italia 96
IN - India 75
FI - Finlandia 71
CA - Canada 50
BD - Bangladesh 46
GB - Regno Unito 38
SE - Svezia 31
CZ - Repubblica Ceca 28
IQ - Iraq 28
AR - Argentina 23
MX - Messico 22
TR - Turchia 21
JP - Giappone 19
NL - Olanda 17
PK - Pakistan 15
EC - Ecuador 13
BE - Belgio 12
CO - Colombia 12
SA - Arabia Saudita 12
PL - Polonia 11
AT - Austria 10
CL - Cile 10
ID - Indonesia 10
MA - Marocco 10
KE - Kenya 9
LT - Lituania 8
PH - Filippine 8
VE - Venezuela 7
ES - Italia 6
UA - Ucraina 6
AZ - Azerbaigian 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
BO - Bolivia 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GN - Guinea 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
OM - Oman 1
SO - Somalia 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
YE - Yemen 1
Totale 6.823
Salva come PNG Salva come JPEG
Città #
Dublin 555
Ashburn 468
San Jose 447
Chandler 334
Hong Kong 287
Singapore 283
Dallas 174
Beijing 160
Boardman 122
Princeton 116
Johannesburg 111
Lauterbourg 100
Lawrence 98
Ho Chi Minh City 89
Medford 80
Los Angeles 66
Shanghai 64
Wilmington 64
Hanoi 50
Washington 49
Helsinki 45
Buffalo 44
Munich 44
Redondo Beach 44
Council Bluffs 41
New York 35
Toronto 26
Moscow 25
Santa Clara 25
Turku 25
São Paulo 23
Brno 22
Pavia 22
Norwalk 18
Nuremberg 17
Ann Arbor 16
Chicago 16
Tokyo 16
Stockholm 15
London 14
Milan 14
Orem 14
Frankfurt am Main 13
The Dalles 13
Chennai 12
Brussels 11
Dhaka 11
Guangzhou 11
Haiphong 11
Columbus 10
Falkenstein 10
New Delhi 10
Saint Louis 10
Atlanta 9
Baghdad 9
Mexico City 9
Nairobi 9
Rio de Janeiro 9
Ankara 8
Brooklyn 8
Düsseldorf 8
Phoenix 8
Seattle 8
Amsterdam 7
Boston 7
Denver 7
Houston 7
Montreal 7
Vienna 7
Warsaw 7
Zhengzhou 7
Belo Horizonte 6
Da Nang 6
Erbil 6
Guayaquil 6
Lahore 6
Pune 6
Redwood City 6
Baku 5
Canyon Country 5
Jakarta 5
Jeddah 5
Olomouc 5
Casablanca 4
Changsha 4
Chengdu 4
Curitiba 4
Dong Ket 4
Goiânia 4
Hangzhou 4
Ludhiana 4
Memphis 4
Ottawa 4
Riyadh 4
Shenzhen 4
Tashkent 4
Tianjin 4
Wuhan 4
Amman 3
Anyang 3
Totale 4.674
Salva come PNG Salva come JPEG
Nome #
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 121
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 120
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 109
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 107
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 102
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 101
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 99
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 98
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 98
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 95
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 93
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 93
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 91
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 91
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 91
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 90
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 88
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 88
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 87
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 87
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 80
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 80
To a new normal in radiation oncology: looking back and planning forward 79
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 78
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 78
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 78
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 77
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 73
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 73
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 71
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 71
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 71
Radiomics features as predictive and prognostic biomarkers in NSCLC 70
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 69
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 69
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 69
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 68
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 67
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 67
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 66
Radiomics features as predictive and prognostic biomarkers in NSCLC 66
Brain metastases from lung cancer: Is MET an actionable target? 66
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 66
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 66
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 65
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 65
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 64
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 63
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 63
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 62
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 61
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 60
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 59
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough? 58
Radiotherapy in Pediatric Oncology 58
Extranodal Marginal Zone Lymphoma 58
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 58
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 57
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 57
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 56
Is clinical radiosensitivity a complex genetically controlled event? 56
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 56
Treatment of metastatic melanoma: a multidisciplinary approach 56
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group 53
Current role and future developments of radiotherapy in Hodgkin's lymphoma 52
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 51
Stereotactic radiotherapy for early stage non-small cell lung cancer 51
Radiation therapy for older patients with brain tumors 50
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 50
Large cohort observational study integrates current knowledge on changes in outcome for melanoma brain metastases in tyrosine kinase inhibitor (TKI)-immunotherapy era 50
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 50
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 49
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 48
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 48
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 48
Emo-linfopatie maligne 47
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 47
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 47
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 46
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 46
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 46
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 45
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 45
Limited stage follicular lymphoma: Current role of radiation therapy 45
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 45
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 44
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 44
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 43
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 43
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 43
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 43
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 43
Stereotactic body radiation therapy for lung metastases 42
Innovative technologies in thoracic radiation therapy for lung cancer 42
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk 42
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 41
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 41
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 40
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 40
Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy 39
Totale 6.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022414 16 0 19 6 7 9 9 29 23 9 68 219
2022/20231.153 134 49 5 68 70 98 3 67 618 4 32 5
2023/2024617 59 67 71 37 73 193 56 12 0 23 1 25
2024/20251.337 43 121 34 47 19 60 46 53 367 73 124 350
2025/20263.196 217 228 273 309 372 129 631 211 341 231 169 85
Totale 6.957